Bleichroeder LP’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.46K | Hold |
595
| – | – | ﹤0.01% | 79 |
|
|
2025
Q4 | $2.38K | Hold |
595
| – | – | ﹤0.01% | 71 |
|
|
2025
Q3 | $2.04K | Hold |
595
| – | – | ﹤0.01% | 71 |
|
|
2025
Q2 | $1.13K | Sell |
595
-1
| -0.2% | -$4 | ﹤0.01% | 76 |
|
|
2025
Q1 | $4.22K | Hold |
596
| – | – | ﹤0.01% | 76 |
|
|
2024
Q4 | $13.1K | Hold |
596
| – | – | ﹤0.01% | 71 |
|
|
2024
Q3 | $12K | Hold |
596
| – | – | ﹤0.01% | 71 |
|
|
2024
Q2 | $10.4K | Hold |
596
| – | – | ﹤0.01% | 71 |
|
|
2024
Q1 | $24.8K | Hold |
596
| – | – | 0.01% | 70 |
|
|
2023
Q4 | $15K | Hold |
596
| – | – | ﹤0.01% | 68 |
|
|
2023
Q3 | $19.5K | Hold |
596
| – | – | ﹤0.01% | 61 |
|
|
2023
Q2 | $34.7K | Sell |
596
-595
| -50% | -$30.6K | 0.01% | 66 |
|
|
2023
Q1 | $31.1K | Hold |
1,191
| – | – | 0.01% | 65 |
|
|
2022
Q4 | $35.5K | Hold |
1,191
| – | – | 0.01% | 64 |
|
|
2022
Q3 | $61K | Hold |
1,191
| – | – | 0.01% | 67 |
|
|
2022
Q2 | $34K | Hold |
1,191
| – | – | 0.01% | 80 |
|
|
2022
Q1 | $63K | Hold |
1,191
| – | – | 0.01% | 97 |
|
|
2021
Q4 | $82K | Hold |
1,191
| – | – | 0.01% | 91 |
|
|
2021
Q3 | $189K | Hold |
1,191
| – | – | 0.03% | 75 |
|
|
2021
Q2 | $232K | Hold |
1,191
| – | – | 0.04% | 71 |
|
|
2021
Q1 | $308K | Hold |
1,191
| – | – | 0.05% | 58 |
|
|
2020
Q4 | $230K | Hold |
1,191
| – | – | 0.04% | 52 |
|
|
2020
Q3 | $242K | Hold |
1,191
| – | – | 0.04% | 55 |
|
|
2020
Q2 | $333K | Hold |
1,191
| – | – | 0.06% | 52 |
|
|
2020
Q1 | $357K | Hold |
1,191
| – | – | 0.09% | 47 |
|
|
2019
Q4 | $382K | Buy |
+1,191
| New | +$427K | 0.06% | 37 |
|
Other funds holding XFOR
EAM
BCLSI
PA
SVCM
DTC
KCM
VCM
B